Detailed answers about NUCLEOTIDE MEDICAL LIMITED, including incorporation, status, business activity, and accounts information.
When was NUCLEOTIDE MEDICAL LIMITED founded?
NUCLEOTIDE MEDICAL LIMITED was officially incorporated on 31 December 2019 and is registered under company number 12381558. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NUCLEOTIDE MEDICAL LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NUCLEOTIDE MEDICAL LIMITED?
NUCLEOTIDE MEDICAL LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NUCLEOTIDE MEDICAL LIMITED do?
NUCLEOTIDE MEDICAL LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is NUCLEOTIDE MEDICAL LIMITED's registered address?
The registered office address of NUCLEOTIDE MEDICAL LIMITED is C/O AACSL ACCOUNTANTS LTD, 1ST FLOOR, NORTH WESTGATE HOUSE, HARLOW, ESSEX, UNITED KINGDOM, CM20 1YS. This is the official address filed with Companies House for legal and statutory correspondence.
Is NUCLEOTIDE MEDICAL LIMITED financially stable?
The most recent accounts for NUCLEOTIDE MEDICAL LIMITED were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.